Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) Publishes 2026 First EGM and H Shareholders’ Class Meeting Circular

Bulletin Express

Feb 04

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) issued a notification on 4 February 2026 regarding the availability of the circular for its 2026 first extraordinary general meeting (EGM) and the 2026 first H shareholders’ class meeting (collectively referred to as the “Current Corporate Communication”). Both the English and Chinese versions are accessible on the company’s official website (www.fosunpharma.com) and on the Hong Kong Stock Exchange website (www.hkexnews.hk).

According to the announcement, non-registered shareholders who face difficulties viewing the circular electronically may request printed copies. They can complete and sign the enclosed request form and submit it by mail to the H share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or send it via email to is-ecom@vistra.com. The company will provide the requested copies free of charge.

The announcement also provides details on how non-registered shareholders can receive corporate communications electronically by liaising with their banks, brokers, custodians, or other nominees. For further inquiries, shareholders may contact Tricor Investor Services Limited at (852) 2980 1333, Monday to Friday (excluding public holidays), from 9:00 a.m. to 6:00 p.m.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1122936409"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1122936409\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1122936409?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-04 19:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122936409","market":"us","top_or_hot":-1,"title":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) Publishes 2026 First EGM and H Shareholders’ Class Meeting Circular","media":"Bulletin Express","content":"<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) issued a notification on 4 February 2026 regarding the availability of the circular for its 2026 first extraordinary general meeting (EGM) and the 2026 first H shareholders’ class meeting (collectively referred to as the “Current Corporate Communication”). Both the English and Chinese versions are accessible on the company’s official website (www.fosunpharma.com) and on the Hong Kong Stock Exchange website (www.hkexnews.hk).</p>\n<p>According to the announcement, non-registered shareholders who face difficulties viewing the circular electronically may request printed copies. They can complete and sign the enclosed request form and submit it by mail to the H share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or send it via email to is-ecom@vistra.com. The company will provide the requested copies free of charge.</p>\n<p>The announcement also provides details on how non-registered shareholders can receive corporate communications electronically by liaising with their banks, brokers, custodians, or other nominees. For further inquiries, shareholders may contact Tricor Investor Services Limited at (852) 2980 1333, Monday to Friday (excluding public holidays), from 9:00 a.m. to 6:00 p.m.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) Publishes 2026 First EGM and H Shareholders’ Class Meeting Circular</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) Publishes 2026 First EGM and H Shareholders’ Class Meeting Circular\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-04 19:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) issued a notification on 4 February 2026 regarding the availability of the circular for its 2026 first extraordinary general meeting (EGM) and the 2026 first H shareholders’ class meeting (collectively referred to as the “Current Corporate Communication”). Both the English and Chinese versions are accessible on the company’s official website (www.fosunpharma.com) and on the Hong Kong Stock Exchange website (www.hkexnews.hk).</p>\n<p>According to the announcement, non-registered shareholders who face difficulties viewing the circular electronically may request printed copies. They can complete and sign the enclosed request form and submit it by mail to the H share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or send it via email to is-ecom@vistra.com. The company will provide the requested copies free of charge.</p>\n<p>The announcement also provides details on how non-registered shareholders can receive corporate communications electronically by liaising with their banks, brokers, custodians, or other nominees. For further inquiries, shareholders may contact Tricor Investor Services Limited at (852) 2980 1333, Monday to Friday (excluding public holidays), from 9:00 a.m. to 6:00 p.m.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02196","symbol_name":"复星医药","start_time":0,"source_url":"","article_id":"1122936409","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122936409","pubTimestamp":1770204271,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) issued a notification on 4 February 2026 regarding the availability of the circular for its 2026 first extraordinary general...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02196":"复星医药"},"translate_title":"上海复星医药（集团）股份有限公司（股份代号：02196）刊发2026年第一次临时股东大会暨H股类别股东大会通函","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02196":1},"content_text":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) issued a notification on 4 February 2026 regarding the availability of the circular for its 2026 first extraordinary general meeting (EGM) and the 2026 first H shareholders’ class meeting (collectively referred to as the “Current Corporate Communication”). Both the English and Chinese versions are accessible on the company’s official website (www.fosunpharma.com) and on the Hong Kong Stock Exchange website (www.hkexnews.hk).\nAccording to the announcement, non-registered shareholders who face difficulties viewing the circular electronically may request printed copies. They can complete and sign the enclosed request form and submit it by mail to the H share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or send it via email to is-ecom@vistra.com. The company will provide the requested copies free of charge.\nThe announcement also provides details on how non-registered shareholders can receive corporate communications electronically by liaising with their banks, brokers, custodians, or other nominees. For further inquiries, shareholders may contact Tricor Investor Services Limited at (852) 2980 1333, Monday to Friday (excluding public holidays), from 9:00 a.m. to 6:00 p.m.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}